Health Care · Life Sciences Tools & Services
Bio-Techne: revenue, profit and dividends
In fiscal 2026, Bio-Techne had revenue of $1.22B, up 9.3% a year on average since 2016, and net income of $182M (15.0% of revenue). It paid a dividend of $0.32 a share. It has 5% more shares than in 2016.
Revenue, fiscal 2026
average annual revenue growth since 2016 · −0.4% vs 2025
- Ticker
- TECH · Nasdaq
- Sector
- Health Care
- Sub-industry
- Life Sciences Tools & Services
- Headquarters
- Minneapolis, Minnesota
- Founded
- 1976
- In the S&P 500 since
- August 30, 2021
- Latest fiscal year
- 2026, ended June 30, 2026
- SEC filer
- BIO-TECHNE Corp · CIK 0000842023
Revenue and net income
Revenue went from $264M in 2009 to $1.22B in 2026.
Diluted earnings per share
Diluted EPS went from $0.69 in 2009 to $1.16 in 2026. Ten-year growth: 5.2% a year.
Dividends per share
Not raised in 2026. Ten-year growth: 0.0% a year.
Shares outstanding
5.2% more shares in 2026 than in 2016 (149M → 157M): new shares outweighed buybacks.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $263M in 2026, 21.7% of revenue.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Dividend | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|---|
| 2026 | $1.22B | $182M | 15.0% | $1.16 | $0.32 | 157M | $292M | $28.9M | $263M |
| 2025 | $1.22B | $73.4M | 6.0% | $0.46 | $0.32 | 160M | $288M | $31M | $257M |
| 2024 | $1.16B | $168M | 14.5% | $1.05 | $0.32 | 161M | $299M | $62.9M | $236M |
| 2023 | $1.14B | $285M | 25.1% | $1.76 | $0.32 | 162M | $254M | $38.2M | $216M |
| 2022 | $1.11B | $272M | 24.6% | $1.66 | $0.32 | 164M | $325M | $44.9M | $280M |
| 2021 | $931M | $140M | 15.1% | $0.87 | $0.32 | 162M | $352M | $44.3M | $308M |
| 2020 | $739M | $229M | 31.0% | $1.46 | $0.32 | 158M | $205M | $51.7M | $153M |
| 2019 | $714M | $96M | 13.4% | $0.62 | $0.32 | 156M | $182M | $25.4M | $156M |
| 2018 | $643M | $126M | 19.6% | $0.83 | $0.32 | 152M | $170M | $20.9M | $149M |
| 2017 | $563M | $76M | 13.5% | $0.51 | $0.32 | 150M | $144M | $15.2M | $129M |
| 2016 | $499M | $104M | 20.9% | $0.70 | $0.32 | 149M | $144M | $16.9M | $127M |
| 2015 | $452M | $108M | 23.8% | $0.72 | $0.32 | 149M | $139M | $19.9M | $119M |
| 2014 | $358M | $111M | 31.0% | $0.75 | $0.31 | 148M | $137M | $13.8M | $123M |
| 2013 | $311M | $113M | 36.2% | $0.76 | $0.29 | 148M | $124M | $22.5M | $101M |
| 2012 | $315M | $112M | 35.7% | $0.76 | $0.28 | 148M | $127M | $6.02M | $121M |
| 2011 | $290M | $112M | 38.7% | $0.76 | $0.27 | 149M | $127M | $3.63M | $124M |
| 2010 | $269M | $110M | 40.8% | $0.73 | $0.26 | 149M | $111M | $4.64M | $107M |
| 2009 | $264M | $105M | 39.9% | $0.69 | $0.19 | 152M | $111M | $6.56M | $105M |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
Stock splits
Found in the filings; per-share figures and share counts on this page are on today’s share basis.
- 4-for-1 split · first reflected in a filing of February 7, 2023
About these figures
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Life Sciences Tools & Services companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.